Fate Therapeutics, Inc. (FATE) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -30.82M | -23.31M | -24.37M | -24.59M | -33.81M | -27.8M | -29.42M | -32.31M | -33.35M | -36.64M | -38.27M | -28.49M |
| Operating CF Margin % | -2372.75% | -1702.99% | -1400% | -1289.3% | -2075.45% | -1494.57% | -957.03% | -477.05% | -1732.47% | -2185.98% | -1968.78% | -3053.91% |
| Operating CF Growth % | 8.83% | 16.13% | 17.15% | 23.89% | -1.38% | 24.12% | 23.13% | -13.38% | -15.56% | 51.4% | 30.47% | 46.4% |
| Net Income | -31.21M | 0 | -32.25M | -34.07M | -37.62M | -52.15M | -47.68M | -38.43M | -48M | -44.12M | -45.17M | -52.76M |
| Depreciation & Amortization | 2.15M | -3.79M | 3.23M | 3.28M | 3.33M | 4.81M | 4.61M | 4.72M | 4.82M | 4.88M | 4.74M | 4.47M |
| Stock-Based Compensation | 3.93M | 0 | 4.86M | 7.15M | 7.38M | 9.12M | 11.77M | 9.63M | 10.98M | 0 | 10.1M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 280K | -20.58M | -716K | -1.02M | -1.53M | 12.33M | -1.24M | -4.44M | -1.76M | 2.79M | -5.13M | 9.76M |
| Working Capital Changes | -5.96M | 1.05M | 504K | 73K | -5.37M | -1.91M | 3.13M | -3.79M | 614K | -189K | -2.82M | 10.04M |
| Change in Receivables | 212K | -233K | 713K | 1.01M | 1.13M | 588K | -2.48M | -190K | 968K | -288K | 1.3M | 10.67M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -5.77M | 865K | 0 | 0 | 0 | 0 | 1.87M | 0 | 0 | -1.89M | 0 | -4.37M |
| Cash from Investing | 23.59M | 27.63M | 21.27M | 19.59M | 42.67M | 22.82M | 25.46M | -53.37M | 17.31M | 45.35M | 24.8M | 33.17M |
| Capital Expenditures | -239K | -1.19M | -2.2M | -1.36M | -1.2M | -98K | -495K | -51K | -86K | -181K | -565K | -2.2M |
| CapEx % of Revenue | 18.4% | 87.07% | 126.54% | 71.42% | 73.42% | 5.27% | 16.1% | 0.75% | 4.47% | 10.8% | 29.06% | 235.69% |
| Acquisitions | 0 | -122K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 359K | 3K | 122K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 1.69M | 2.48M | 1.32M | 0 | 3.13M | 0 | 1.27M | 95.49M | -180K | 0 | 58K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -662K | 75.19M | -180K | 0 | 58K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 1.69M | 2.48M | 1.32M | 0 | 3.13M | 0 | 1.94M | 20.3M | 0 | 0 | 0 |
| Net Change in Cash | -7.24M | 6.01M | -627K | -3.67M | 8.86M | -1.85M | 992K | -84.41M | 79.45M | 8.54M | -13.47M | 4.78M |
| Free Cash Flow | -31.06M | -24.51M | -26.58M | -25.95M | -35.01M | -27.9M | -29.91M | -32.36M | -33.44M | -36.82M | -38.84M | -30.69M |
| FCF Margin % | -2391.15% | -1790.07% | -1526.54% | -1360.72% | -2148.86% | -1499.84% | -973.13% | -477.81% | -1736.94% | -2196.78% | -1997.84% | -3289.6% |
| FCF Growth % | 11.27% | 12.16% | 11.16% | 19.8% | -4.69% | 24.23% | 22.98% | -5.42% | -4.27% | 55.14% | 39.05% | 51.5% |
| FCF per Share | -0.26 | -0.21 | -0.22 | -0.22 | -0.30 | -0.24 | -0.25 | -0.28 | -0.33 | -0.37 | -0.39 | -0.31 |
| FCF Conversion (FCF/Net Income) | 0.99x | 0.72x | 0.76x | 0.72x | 0.90x | 0.53x | 0.62x | 0.84x | 0.69x | 0.83x | 0.85x | 0.54x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |